35 Flashcards

1
Q

Why is good evidence vital?

A
  • Ineffective treatments are used
  • Give treatments for which harms outweigh the benefits
  • Fail to provide effective interventions
  • New expensive treatments may be no better then older
    cheaper ones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is it difficult to communicate all the evidence

A
  • Adverts backed up by dubious scientific claims
  • Endorsements by prominent people
  • Scares and conspiracy theories
  • The value that people place on individual stories may lead
    people to ignore objective evidence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Primary level of prevention

A

interventions that attempt to prevent disease from occurring - reduce the incidence of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Secondary levels of prevention

A

redcue impact of disease by shortening its duration, reducing severity or preventing reoccurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Tertiary levels of prevention

A

reduce the number or impact of complications: improve rehabilitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Population/ mass approaches

A

aims to reduce the health risks of the entire population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

High risk strategy

A

individuals in special need are identified

the preventive process then takes the form of controlling the level of exposure to a cause or providing protection against the consequences of the exposure in the high risk group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Advantages and disadvantages of population/ mass strategy

A

Advenantges
- radical
- Behavouly appropriate
- Large potential for whole population

Disadvantages
- small benefit to individuals
- Poor motivation of individuals
- Benefit-to-risk ratio may be low for individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

High risk / individual strategy advances and disadvantages

A

Advantages
- appropriate to individuals
- Individual motivation
- Clinical motivation
- Favourable benefit-risk ratio for individuals

Disadvantages
- need to identify individuals
- Might be against population norms
- Can be hard to sustain behavioural change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PREVENTION PARADOX:

A

a large number of people at small risk may give rise to more cases of disease then the small number who are at high risk
a preventive measure that brings large benefit to the community may offer little to each participating individual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is screening

A

The widespread use of a simple test for a disease in an apparently health population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a screening programme

A

An organised system using a screening test among asymptomatic people in the population to identify early cases of disease in order to improve outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Screening test

A

A test, usually relatively cheap and simple, used to test large numbers of apparently health people to identify individuals suspected of having easily disease who will then go on to have further diagnosis tests to confirm the diagnosis.
A screening test differs from a diagnostic test in that there is greater emphasis on cost and safety… and less on definitive diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A screening test is not a diagnostic test, a screening test is not a screening programme

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Screening is a pathway not a test

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Screeening programmes are different from base finding or opportunistic screening

A
17
Q

Because screening is resource intensive we usually do it when

A

High prevalence of pre-clinical disease

UNLESS:
- serious disease
- cheap and easy to administer

18
Q

ong lead time = greater chance of detecting disease early

A
19
Q

Critical points

A
  1. Disease is not detectable
  2. Usually diagnosed anyway – no benefit
  3. Screening may be of benefit
20
Q
A

Over treatment
Over diagnosis
Over treatment

21
Q

PVs are influenced by…

A

Disease prevalence in the population of interest, unlike sensitivity and specificity

22
Q

Is the programme effective?

A

Evidence from Randomized Controlled Trials of benefit (reduced mortality and/or morbidity) prior to initiation
Ongoing evaluation of programmes once implemented

Crucial to determine if screening programme actually leads to benefit

23
Q

Benefits of screening programmes

A

Potential for early detection and intervention – reduced mortality and/or morbidity
– possibly less radical treatment required
• Reassurance (true negatives)
• Improved health of population

24
Q

Harms of screening programmes

A
  1. Increase health inequities
  2. Physical
  3. Physiological
  4. Financial
25
Q

Over-diagnosis and/or over-treatment- may…..

A

Increase morbidity without reducing mortality

  • False positives- period of stress and uncertainty until diagnostic test
    • May diagnose a disease that would never have become apparent

LEAD TIME BIAS

26
Q

L ength bias

A

Screening is biased towards detecting slowly- developing disease that may never have required treatment ( therefore better prognosis)

27
Q

Length bias

A

Screening is biased towards detecting slowly- developing disease that may never have required treatment ( therefore better prognosis)

28
Q

When to screen: disease

A
  • Seriousness of disease
    • Prevalence of pre-clinical disease
    • Lead time
    • Ability to alter the course of disease – point where prognosis can be improved
    – effective treatment available?
29
Q

Is the test accurate?

A

Sensitivity, specificity, PPV, NPV